Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page has updated the version number from v2.15.0 to v2.15.2 and removed a specific citation related to a study on renal cell carcinoma.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study information regarding a clinical trial for advanced or metastatic clear-cell renal cell carcinoma, while adding a new version number and collaborators.SummaryDifference5%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.